<DOC>
	<DOCNO>NCT00577499</DOCNO>
	<brief_summary>Cystic fibrosis ( CF ) result thicken secretion multiple organ system include lung gastrointestinal ( GI ) tract . Patients commonly suffer nutritional deficiency , achieve maintain adequate nutrition important goal therapy positively correlate lung function . Lubiprostone activate chloride channel GI tract . Because mechanism action closely parallels disease pathology , lubiprostone potential provide GI benefit beyond relief constipation . This project observational study examine effect lubiprostone nutritional status lung function adult CF . Our hypothesis lubiprostone beneficial effect nutritional status .</brief_summary>
	<brief_title>Effect Lubiprostone Nutritional Status Pulmonary Function Adults With Cystic Fibrosis</brief_title>
	<detailed_description>Background : Cystic fibrosis ( CF ) affect estimate 30,000 people United States . It cause mutation gene encode protein call cystic fibrosis transmembrane regulator ( CFTR ) . This protein function chloride channel epithelial cell multiple organ system . The mutation result dysfunctional absent CFTR channel decrease chloride secretion , result thicken secretion multiple organ system include lung gastrointestinal ( GI ) tract . This patient population commonly suffer nutritional deficiency , achieve maintain normal nutritional status important goal therapy body mass index ( BMI ) positively correlate forced expiratory volume 1 second ( FEV1 ) , measure pulmonary function . Lubiprostone activate type 2 chloride channel ( ClC-2 ) apical membrane GI epithelial cell . Because mechanism action closely parallels disease pathology , lubiprostone potential provide GI benefit beyond relief constipation . Objectives : The propose pilot project prospective observational study examine effect lubiprostone adult CF . The specific aim determine effect lubiprostone : 1 ) nutritional marker 2 ) pulmonary function adult CF . Methods : Adults CF currently take lubiprostone chronically seek enrollment . Study subject follow approximately 3-months serial assessment indicator nutrition pulmonary function . Nutritional marker measure include body weight , albumin , prealbumin , vitamins A , D , E. Pulmonary function assess pulmonary function test , survey monitor symptom pulmonary exacerbation , monitor frequency hospitalization IV antibiotic use . Expected Results : We expect see beneficial effect nutritional marker , body weight , BMI . We hope translates concomitant improvement pulmonary function .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Lubiprostone</mesh_term>
	<criteria>Planning currently chronic lubiprostone therapy ( chronic define least one 24 microgram capsule mouth every day Body mass index ( BMI ) less 22 female less 23 male initiation chronic lubiprostone therapy Initiation chronic lubiprostone therapy within 1 month enrollment Age 18 Currently take multivitamin History noncompliance medication CF therapy History hospital admission CF exacerbation â‰¥2 last 6 month FEV1 les 40 % expect ( severe dysfunction ) recent assessment ambulatory set Currently register lung transplant wait list Any condition , opinion investigator , interfere ability study subject comply study requirement , confers significant risk , limit ability subject complete study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>cystic fibrosis</keyword>
	<keyword>constipation</keyword>
	<keyword>lubiprostone</keyword>
	<keyword>nutrition</keyword>
	<keyword>pulmonary function</keyword>
</DOC>